Company Search:
Advanced Search
Sponsored Links
Microbot Medical Inc Company Snapshot
Microbot Medical Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Microbot Medical Inc with three other companies in this sector in the United States: CASI Pharmaceuticals Inc (2015 sales of $47,712.00 ), CytRx Corporation ($100,000.00 of which 100% was Pharmaceutical Product Developers), and Hemispherx Biopharma, Inc. ($133,000.00 of which 100% was Biomedical R & D).

Sales Analysis. Sales fell dramatically in 2015: During the year ended December of 2015, sales at Microbot Medical Inc were $116,887.00 . This is a sharp decrease of 88.5% versus 2014, when the company's sales were $1.01 million.
  Stock Performance Chart for Microbot Medical Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 1.07
(Figures in U.S. Dollars)
1 Week 0.9%   13 Weeks 2.9%  
4 Weeks -10.1%   52 Weeks -79.4%  
Microbot Medical Inc Key Data:
  Ticker: MBOT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 116,887
(Year Ending Jan 2016).
Employees: 7
  Currency: U.S. Dollars Market Cap: 41,307,706
  Fiscal Yr Ends: December Shares Outstanding: 38,605,333
  Share Type: Common Closely Held Shares: 20,337,851
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.